Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control.

Saito J, Gibeon D, Macedo P, Menzies-Gow A, Bhavsar PK, Chung KF.

Eur Respir J. 2014 Feb;43(2):474-84. doi: 10.1183/09031936.00048513. Epub 2013 Aug 15.

2.

Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics.

Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N.

Chest. 2006 Jun;129(6):1492-9.

PMID:
16778266
3.

Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.

Paro-Heitor ML, Bussamra MH, Saraiva-Romanholo BM, Martins MA, Okay TS, Rodrigues JC.

Pediatr Pulmonol. 2008 Feb;43(2):134-41.

PMID:
18085692
4.

Stratifying a risk for an increased variation of airway caliber among the clinically stable asthma.

Hayata A, Matsunaga K, Hirano T, Akamatsu K, Ichikawa T, Minakata Y, Ichinose M.

Allergol Int. 2013 Sep;62(3):343-9. doi: 10.2332/allergolint.13-OA-0543. Epub 2013 Jul 25.

5.

Exhaled nitric oxide fraction as an add-on to ACQ-7 for not well controlled asthma detection.

Plaza V, Ramos-Barbón D, Muñoz AM, Fortuna AM, Crespo A, Murio C, Palomino R; EOLO Study Investigators.

PLoS One. 2013 Oct 25;8(10):e77085. doi: 10.1371/journal.pone.0077085. eCollection 2013.

6.

Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial.

Anderson WJ, Short PM, Williamson PA, Lipworth BJ.

Chest. 2012 Dec;142(6):1553-61. doi: 10.1378/chest.12-1310.

PMID:
23364390
7.

Exhaled nitric oxide predicts persistence of wheezing, exacerbations, and decline in lung function in wheezy infants and toddlers.

Elliott M, Heltshe SL, Stamey DC, Cochrane ES, Redding GJ, Debley JS.

Clin Exp Allergy. 2013 Dec;43(12):1351-61. doi: 10.1111/cea.12171.

8.

[Comparison of the Asthma Control Test (ACT) with lung function, levels of exhaled nitric oxide and control according to the Global Initiative for Asthma (GINA)].

Alvarez-Gutiérrez FJ, Medina-Gallardo JF, Pérez-Navarro P, Martín-Villasclaras JJ, Martin Etchegoren B, Romero-Romero B, Praena-Fernández JM.

Arch Bronconeumol. 2010 Jul;46(7):370-7. doi: 10.1016/j.arbres.2010.04.003. Spanish.

9.

Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations.

Ko FW, Hui DS, Leung TF, Chu HY, Wong GW, Tung AH, Ngai JC, Ng SS, Lai CK.

Respirology. 2012 Feb;17(2):370-8. doi: 10.1111/j.1440-1843.2011.02105.x.

PMID:
22107482
10.

Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.

Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K.

Pulm Pharmacol Ther. 2014 Feb;27(1):52-6. doi: 10.1016/j.pupt.2013.04.001. Epub 2013 Apr 11.

PMID:
23583566
11.

Daily ambulatory exhaled nitric oxide measurements in asthma.

Pijnenburg MW, Floor SE, Hop WC, De Jongste JC.

Pediatr Allergy Immunol. 2006 May;17(3):189-93.

PMID:
16672005
12.

Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children.

Stern G, de Jongste J, van der Valk R, Baraldi E, Carraro S, Thamrin C, Frey U.

J Allergy Clin Immunol. 2011 Aug;128(2):293-300. doi: 10.1016/j.jaci.2011.03.010. Epub 2011 Apr 13.

PMID:
21489612
13.

Increased IL-17A secreting CD4+ T cells, serum IL-17 levels and exhaled nitric oxide are correlated with childhood asthma severity.

Chien JW, Lin CY, Yang KD, Lin CH, Kao JK, Tsai YG.

Clin Exp Allergy. 2013 Sep;43(9):1018-26. doi: 10.1111/cea.12119.

PMID:
23957337
14.

Association of asthma education with asthma control evaluated by asthma control test, FEV1, and fractional exhaled nitric oxide.

Saito J, Sato S, Fukuhara A, Sato Y, Nikaido T, Inokoshi Y, Fukuhara N, Saito K, Ishii T, Tanino Y, Ishida T, Munakata M.

J Asthma. 2013 Feb;50(1):97-102. doi: 10.3109/02770903.2012.741638. Epub 2012 Nov 19.

PMID:
23163920
15.

Fractioned exhaled nitric oxide (FE(NO)) is not a sufficiently reliable test for monitoring asthma in pregnancy.

Nittner-Marszalska M, Liebhart J, Pawłowicz R, Kazimierczak A, Marszalska H, Kraus-Filarska M, Panaszek B, Dor-Wojnarowska A.

Nitric Oxide. 2013 Sep 1;33:56-63. doi: 10.1016/j.niox.2013.06.001. Epub 2013 Jun 10.

PMID:
23756211
16.

Exhaled nitric oxide and clinical phenotypes of childhood asthma.

Mahut B, Peyrard S, Delclaux C.

Respir Res. 2011 May 20;12:65. doi: 10.1186/1465-9921-12-65.

17.

Daily exhaled nitric oxide measurements and asthma exacerbations in children.

van der Valk RJ, Baraldi E, Stern G, Frey U, de Jongste JC.

Allergy. 2012 Feb;67(2):265-71. doi: 10.1111/j.1398-9995.2011.02734.x. Epub 2011 Oct 17.

18.

Association of longitudinal fractional exhaled nitric oxide measurements with asthma control in atopic children.

Yang S, Park J, Lee YK, Kim H, Hahn YS.

Respir Med. 2015 May;109(5):572-9. doi: 10.1016/j.rmed.2015.03.003. Epub 2015 Mar 21.

PMID:
25840483
19.

Usefulness of impulse oscillometry and fractional exhaled nitric oxide in children with Eosinophilic bronchitis.

Kim YH, Kim KW, Baek J, Park HB, Kim H, Song KJ, Lee JM, Sohn MH, Kim KE.

Pediatr Pulmonol. 2013 Mar;48(3):221-8. doi: 10.1002/ppul.22631. Epub 2012 Jul 23.

PMID:
22825832
20.

[The long-term variability of FeNO in pregnant asthmatic women with controlled asthma].

Dor-Wojnarowska A, Nittner-Marszalska M, Liebhart J, Marszalska H, Pawłowicz R, Gillert M, Kazimierczak A, -Filarska MK, Panaszek B.

Pneumonol Alergol Pol. 2013;81(2):114-20. Polish.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk